AI in Healthcare December 13, 2021
Michael Walter

The FDA has published a new discussion paper focused on regulating 3D-printed medical devices manufactured at the point of care.

The agency’s Center for Devices and Radiological Health (CDRH) shared the document on Dec. 10, requesting feedback from “the medical device industry, manufacturers, healthcare providers, healthcare facilities and other stakeholders.”

“The 3D printing of medical devices is at the forefront of innovation and healthcare,” William Maisel, MD, director of the CDRH’s Office or Product Evaluation and Quality, and Ed Margerrison, PhD, director of the Office of Science and Engineering Laboratories, said in a prepared statement. “3D printing at hospitals and other patient-care settings enables health care professionals to quickly create patient-matched devices and anatomical models for surgical planning, as well...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, FDA, Govt Agencies, Medical Devices, Provider, Technology
Listen: What the mifepristone case means, GLP-1 skepticism, & Chinese biotech
FDA approves Akebia anemia pill, two years after rejection
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
FDA approves Merck drug for rare lung disorder
Neuronetics wins FDA clearance for device to treat adolescents with depression

Share This Article